mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
0.031 |
0.4 |
mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.033 |
0.4 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.03 |
0.4 |
mRNA |
SID 26681509 |
CTRPv2 |
pan-cancer |
AAC |
0.035 |
0.4 |
mRNA |
BRD-A02303741:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.034 |
0.4 |
mRNA |
GSK1120212 |
CTRPv2 |
pan-cancer |
AAC |
0.045 |
0.4 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.032 |
0.4 |
mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.025 |
0.4 |
mRNA |
KPT185 |
CTRPv2 |
pan-cancer |
AAC |
0.034 |
0.4 |
mRNA |
BRD-K01737880 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.4 |